* Relvar Ellipta 100/25 mcg gains approval in Japan for use
in patients with COPD
The post BRIEF-GSK’s lung drug gains approval in Japan appeared first on NASDAQ.
Forex – financial instrument.Forex news
* Relvar Ellipta 100/25 mcg gains approval in Japan for use
in patients with COPD
The post BRIEF-GSK’s lung drug gains approval in Japan appeared first on NASDAQ.